GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
W

Waverley Pharma WAVE.V · CAD

Health Care · TSX Venture · 🇨🇦 Canada

Compare

0.02

—

Close of 2 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in CAD, from our data supplier.

FY2025

Revenue

C$1.3m

FY2016FY2025

Net income

−C$499,214

FY2016FY2025

Free cash flow

−C$611,033

FY2016FY2025

Shareholders' equity

−C$2.6m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueC$1.3mC$475,373C$412,090C$1.2mC$1.8mC$1.4mC$1.2mC$223,401——
Research and developmentC$13,458C$423,659C$234,578C$81,656C$53,789C$53,432C$87,204C$724,888C$31,330C$913
Operating income−C$349,342−C$743,573−C$1.2m−C$936,145−C$786,826−C$709,601−C$1.4m−C$1.5m−C$2.4m−C$1,078
Net income−C$499,214−C$947,077−C$2.2m−C$664,076−C$796,507−C$705,763−C$1.2m−C$1.4m−C$2.4m−C$1,078
Diluted earnings per share-0.01-0.02-0.04-0.01-0.01-0.01-0.02-0.03-0.05-0.00

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsC$1.2mC$2.0mC$952,293C$2.7mC$3.7mC$3.5mC$4.4mC$5.2mC$6.7mC$100
Total liabilitiesC$3.8mC$4.1mC$2.1mC$1.6mC$1.9mC$1.4mC$1.5mC$1.3mC$1.6mC$11,724
Debt—————C$40,000————
Shareholders' equity−C$2.6m−C$2.0m−C$1.1mC$1.1mC$1.8mC$2.0mC$2.8mC$4.0mC$5.1m−C$11,624
Shares outstanding54m54m54m54m54m54m54m54m47m54m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−C$611,033−C$410,192−C$1.0m−C$237,063−C$798,778−C$361,705−C$1.4m−C$1.5m−C$108,690−C$108,690
Free cash flow−C$611,033−C$410,192−C$1.0m−C$237,063−C$798,778−C$361,705−C$1.4m−C$1.5m−C$108,690−C$108,690

Growth per year

Compound annual rate

3 years5 years10 years
Revenue2.7%-0.4%—
Operating income-28.0%-13.2%41.8%
Net income-9.1%-6.7%46.9%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-59.9%-93.7%-72.0%—
Net margin-79.3%-124.4%-88.3%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2018
Price to earnings-0.3-0.0——
Price to sales0.10.00.00.0

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.